KEYMAKER-U03 Substudy 03B: Pembrolizumab (pembro) and novel immunotherapy agents for advanced clear cell renal cell carcinoma (ccRCC)
Suárez, C. Albiges, L. Beckermann, K. Hammers, H. J. Stadler, W. M. Miller, W. H., Jr. Rojas, C. Peer, A. Goh, J. C. Park, S. H.
Suárez, C.
Albiges, L.
Beckermann, K.
Hammers, H. J.
Stadler, W. M.
Miller, W. H., Jr.
Rojas, C.
Peer, A.
Goh, J. C.
Park, S. H.
Abstract
Affiliation
Description
Date
2025
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Suárez C, Albiges L, Beckermann K, Hammers HJ, Stadler WM, Miller WH, Jr., et al. KEYMAKER-U03 Substudy 03B: Pembrolizumab (pembro) and novel immunotherapy agents for advanced clear cell renal cell carcinoma (ccRCC). JOURNAL OF CLINICAL ONCOLOGY. 2025 FEB 10;43(5_SUPPL):552-. PubMed PMID: WOS:001454684700047. English.